These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14963070)

  • 1. Immunosuppressive drugs as an adjuvant to HIV treatment.
    Fumero E; García F; Gatell JM
    J Antimicrob Chemother; 2004 Mar; 53(3):415-7. PubMed ID: 14963070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of immune modulation in the effective long-term control of HIV-1 infection.
    Rizzardi GP; Lazzarin A; Pantaleo G
    J Biol Regul Homeost Agents; 2002; 16(1):83-90. PubMed ID: 12003181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomide.
    Ravot E; Lisziewicz J; Lori F
    Drugs; 1999 Dec; 58(6):953-63. PubMed ID: 10651384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir).
    Lori F; Jessen H; Lieberman J; Clerici M; Tinelli C; Lisziewicz J
    AIDS Res Hum Retroviruses; 1999 May; 15(7):619-24. PubMed ID: 10331440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses.
    Lori F; Foli A; Maserati R; Seminari E; Xu J; Whitman L; Ravot E; Alberici F; Lopalco L; Lisziewicz J
    HIV Clin Trials; 2002; 3(2):115-24. PubMed ID: 11976989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy.
    Barreiro P; de Mendoza C; Camino N; García-Benayas T; Blanco F; Núñez M; González-Lahoz J; Soriano V
    HIV Clin Trials; 2003; 4(6):361-71. PubMed ID: 14628279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters.
    Lori F; Rosenberg E; Lieberman J; Foli A; Maserati R; Seminari E; Alberici F; Walker B; Lisziewicz J
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1333-8. PubMed ID: 10515148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hydroxyurea and HIV infection].
    Nkoghe D; Kola L; Léonard P; Demonty J; Moutschen M
    Rev Med Liege; 2000 Jul; 55(7):721-4. PubMed ID: 11014107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo.
    Chapuis AG; Paolo Rizzardi G; D'Agostino C; Attinger A; Knabenhans C; Fleury S; Acha-Orbea H; Pantaleo G
    Nat Med; 2000 Jul; 6(7):762-8. PubMed ID: 10888924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seminal reservoirs during an HIV type 1 eradication trial.
    Nunnari G; Leto D; Sullivan J; Xu Y; Mehlman KE; Kulkosky J; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2005 Sep; 21(9):768-75. PubMed ID: 16218800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hydroxyurea during structured treatment interruptions.
    Foli A; Seminari E; Ravot E; Lisziewicz J; Lori F
    J Biol Regul Homeost Agents; 2002; 16(1):64-8. PubMed ID: 12003177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
    Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
    J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients.
    Vrisekoop N; Sankatsing SU; Jansen CA; Roos MT; Otto SA; Schuitemaker H; Lange JM; Prins JM; Miedema F
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):991-6. PubMed ID: 16379601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy and therapeutic vaccines in HIV infection.
    García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.